John Reveille

33PUBLICATIONS
66CO-AUTHORS
AutoimmunityRheumatology and arthritisSocial epidemiologySpeech pathologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Dec 19, 2025
Does HLA-B27 Status Influence Ixekizumab Efficacy in Axial Spondyloarthritis? Results From the COAST-V, COAST-W, and COAST-X Trials.

John D Reveille, Martin Rudwaleit, Proton Rahman

|Sep 15, 2025
Global epidemiology of spondyloarthritis.

John D Reveille, Lihi Eder, Nelly Ziade

|Jul 17, 2025
Individualizing NSAID therapy in axial spondyloarthritis: N-of-1 trials with Bayesian analysis.

Mark C Hwang, Seokhun Kim, Shervin Assassi

|Mar 13, 2025
Associations of sociodemographic, clinical factors and HLA-B alleles with enthesitis and peripheral arthritis in patients with ankylosing spondylitis.

Benjamin Sornrung Naovarat, Lianne Gensler, Michael Ward

|Dec 10, 2023
Goodbye to the term 'ankylosing spondylitis', hello 'axial spondyloarthritis': time to embrace the ASAS-defined nomenclature.

Désirée van der Heijde, Anna Molto, Sofia Ramiro

|Oct 01, 2022
Why Do Some Patients Have Severe Sacroiliac Disease But No Syndesmophytes in Ankylosing Spondylitis? Data From a Nested Case-Control Study.

Lauren K Ridley, Mark C Hwang, John D Reveille

Pageof 6

Frequent Collaborators

6 joint publications

Mark Hwang

6 joint publications

Matthew A Brown

5 joint publications

Lianne S Gensler

5 joint publications

Michael H Weisman